Metanephric development
Introduction
Murine metanephric development starts when the ureteric bud, an outgrowth of the Wolffian duct, undergoes branching morphogenesis induced by signals from the surrounding mesenchymal and stromal cells (Carroll and McMahon, 2003; Shah et al., 2004) . In turn, signals from the ureteric bud induce mesenchymal cells to condensate and epithelialize forming the nephron from glomeruli to distal tubules (Grobstein, 1953 (Grobstein, , 1956 Shah et al., 2004) . A stereotyped and iterative process of ureteric bud branching and elongation results in the development of the urinary collecting system (Saxen, 1987; Qiao et al., 1995) . Timely and orderly ureteric bud branching is critical for normal kidney development (Al-Awqati and Goldberg, 1998; Vainio and Lin, 2002) . Mutations that impair ureteric bud branching directly or indirectly result in renal agenesis or hypoplasia whereas those that increase branching result in multiple and/or disorganized kidneys (Schuchardt et al., 1996; Sakai et al., 2003; Majumdar et al., 2003; Grieshammer et al., 2004; Basson et al., 2005) .
The requirement for glial cell-line derived neurotrophic factor (GDNF) signaling for ureteric bud branching is wellestablished (Schuchardt et al., 1996; Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996; Cacalano et al., 1998; Enomoto et al., 1998) . GDNF is necessary for ureteric bud induction, branching, survival, proliferation and chemotactic processes but is not the sole determinant of the ureteric bud pattern (Towers et al., 1998; Pepicelli et al., 1997; Vega et al., 1996; Brophy et al., 2001; Shakya et al., 2005a Shakya et al., , 2005b . It was recently shown that GDNF acts mainly as a ramogen, i.e. induces branching (Shakya et al., 2005a) , in addition to acting as a chemoattractant for ureteric bud tips (Tang et al., 1998 and Dressler, 1997; Sariola and Saarma, 2003) . Positive or negative regulation of this pathway results in major alterations in renal organogenesis and nephron number (Sariola and Saarma, 2003; Cullen-McEwen et al., 2001; Michos et al., 2004; Kuure et al., 2005; Grieshammer et al., 2004; Chi et al., 2004; Basson et al., 2005) . Multiple proteins expressed by the metanephric mesenchyme provide paracrine patterning cues for ureteric bud branching (reviewed in Schedl and Hastie, 2000; Bush et al., 2004) . However, the importance of negative regulators has recently become apparent (Grieshammer et al., 2004; Michos et al., 2004; Basson et al., 2005; Nelson et al., 2006) . For example, it was elegantly demonstrated that slit2 signaling regulates the site and level of expression of GDNF, indicating that guidance proteins contribute to ureteric bud patterning (Grieshammer et al., 2004) .
Secreted class 3 semaphorins and their receptors are guidance proteins necessary for neural and vascular pathfinding during development (Goshima et al., 2002; Deutsch, 2004; Potiron and Roche, 2005) . Disruption of the Sema3a, 3c and 3e genes in mice results in neural, cardiac, and vascular patterning defects (Behar et al., 1996; Feiner et al., 2001; Gitler et al., 2004; Torres-Vazquez et al., 2004; Gu et al., 2005) . Furthermore, Sema3a and 3c modulate branching morphogenesis of the lung epithelial tube (Ito et al., 2000; Kagoshima and Ito, 2001; Hinck, 2004) . In the kidney, Sema3a is expressed by epithelial cells throughout development, including podocytes and ureteric bud cells (Villegas and Tufro, 2002) . In cultured podocytes SEMA3A regulates podocin expression and induces apoptosis (Guan et al., 2006) . The function of Sema3a in the ureteric bud during renal development and in ureteric bud-derived cells later on is unknown.
Here we examined the role of Sema3a in ureteric bud branching morphogenesis using metanephric organ cultures and Sema3a mutant mice. We show that in wild-type metanephric kidneys Sema3a knockdown increases ureteric bud branching. Conversely, recombinant SEMA3A inhibits ureteric bud branching and decreases the number of developing glomeruli in vitro. Mechanistically, our studies indicate that the ureteric bud epithelium expresses Sema3a receptor, neuropilin-1, that SEMA3A downregulates GDNF signaling, and that VEGF 165 rescues SEMA3A-induced decrease in branching morphogenesis. In addition, we report that Sema3a null mutation in mice results in enhanced ureteric bud branching, confirming Sema3a inhibitory role in vivo. These findings suggest that Sema3a functions as a negative regulator of ureteric bud branching during normal kidney development, by modulating GDNF signaling.
Results

Sema3a knockdown increases ureteric bud branching
To define the role of Sema3a in ureteric bud branching we knockeddown endogenous Sema3a using antisense morpholinos (Summerton and Weller, 1997) . We optimized morpholino delivery to the explants by binding them to a translocator peptide (DMPG) that improves cellular uptake of the oligonucleotides (Simeoni et al., 2003) . Two sets of experiments were performed: antisense or mismatched Sema3a morpholinos were either injected into the ureteric bud lumen (Fig. 1A and B) or added to the explant media. To document the specificity of Sema3a antisense morpholinos to block the translation of Sema3a mRNA, in vitro transcription and translation experiments were performed using a reticulocyte lysate system. As shown in Fig. 1C , full-length Sema3a was synthesized in control conditions and in the presence of mismatched morpholino, as indicated by $90 kDa bands, whereas SEMA3A protein synthesis was significantly impaired by antisense Sema3a morpholino. These findings support the ability of this antisense morpholino to specifically knockdown Sema3a expression in eukaryotic cells.
Antisense Sema3a morpholinos induced a significant increase in ureteric bud branching in both sets of experiments. Mismatched Sema3a morpholinos and DMPG alone did not alter explant growth or ureteric bud branching ( Fig. 1D and F) . As shown in Fig. 1D -H, the number of ureteric bud tips increased $60% in Sema3a antisense vs. mismatched morpholino paired explants (20.5 ± 1.9 vs. 13 ± 1.2, n = 5, p < 0.05) in 24 h, whereas the number of ureteric bud tips in explants injected with mismatched morpholinos was not different from controls (13 ± 1.2 vs. 11 ± 1.8, n = 5, p = NS). Moreover, explants exposed to Sema3a antisense morpholino in the media showed a significant increase in ureteric bud branching generations, total number of tips and glomerular number as compared to paired explants exposed to mismatched morpholinos or control explants, as summarized in Table 1 and illustrated in Fig. 1I -N. Taken together, these loss-offunction experiments indicate that SEMA3A, produced by the embryonic kidney, plays an important role in limiting ureteric bud branching morphogenesis and the resulting glomerular number.
2.2.
Recombinant SEMA3A decreases ureteric bud branching To define SEMA3A role as a negative regulator of ureteric bud branching morphogenesis, paired kidney explants were exposed to media or media + recombinant SEMA3A (rSE-MA3A) for 48 or 72 h. As shown in Fig. 2A -E, rSEMA3A significantly decreased the number of ureteric bud branching generations in a concentration dependent manner. Further analysis of explants exposed to rSEMA3A for 48 h (Fig. 2I-K ) revealed a significant decrease in the number of branching generations, lateral branches, and ureteric bud tips as compared to controls (Fig. 2F-H) . These morphometric data, summarized in Table 1 , indicate that rSEMA3A inhibits ureteric bud branching morphogenesis. As shown in Fig. 2G and J and Table 1 , rSEMA3A decreased the number of glomeruli developing in the explants, detected by fluorescent PNA labeling. The relationship between the total number of glomeruli and ureteric bud tips was not altered by rSEMA3A (ratio = 0.81 ± 0.07 vs. 0.82 ± 0.1, p = NS) and was consistent with that reported at this stage of renal development (Al-Awqati and Goldberg, 1998; Vainio and Lin, 2002; Cebrian et al., 2004) . Collectively, these data suggest that SEMA3A did not perturb glomerular development per se and that the decreased glomerular number was due to impaired ureteric bud branching.
2.3.
VEGF 165 partially rescues the ureteric branching defect induced by SEMA3A SEMA3A and vascular endothelial growth factor (VEGF 165 ) compete for binding to their common co-receptor neuropilin-1 in endothelial cells (Miao et al., 1999) , and VEGF 165 stimulates explant growth, tubulogenesis (Tufro-McReddie et al., 1997; Tufro, 2000) and ureteric bud branching (Gao et al., 2005; A. Tufro, unpublished results ). Thus, we tested whether VEGF 165 would rescue the rSEMA3A-induced phenotype. These experiments showed that VEGF 165 partially rescues the ureteric bud defects induced by rSEMA3A by stimulating explant growth and increasing the number of ureteric bud tips (Fig. 3) , suggesting that SEMA3A and VEGF 165 compete for neuropilin-1 binding in ureteric buds, which in turn determines the direction of the signaling cue.
SEMA3A impairs GDNF signaling in vitro
To begin to examine the mechanism of rSEMA3A-induced blunting of ureteric bud branching and determine whether SEMA3A can signal directly in ureteric bud cells, we examined the expression of the SEMA3A receptor neuropilin-1 in embryonic kidneys. As shown in Fig. 4 , neuropilin-1 is expressed in ureteric buds and co-localizes with the ureteric bud marker calbindin in E15 mouse kidneys, suggesting that rSEMA3A effects may be direct and autocrine. Since GDNF plays a central role in ureteric bud branching, we next examined whether SEMA3A regulates GDNF signaling in metanephric explants. Western analysis using paired explants showed that rSEMA3A significantly suppresses GDNF expression and RET tyrosine phosphorylation (Fig. 4I ). In addition, rSEMA3A decreased Akt phosphorylation whereas total Akt expression remained unchanged in the explants (Fig. 4J ), indicating that SEMA3A decreases the activity of the Akt survival pathway. Taken together, these data suggest that Sema3a inhibits ureteric bud branching by downregulating GDNF expression and signaling, and by decreasing the activity of survival pathways.
Sema3a null mutation results in increased ureteric bud branching
To determine the relevance of Sema3a inhibitory effect on ureteric bud branching in vivo, we generated Sema3a heterozygous mice expressing GFP in the ureteric bud (H7-GFP:Sema3a +/À) by breeding previously characterized Sema3a heterozygous mice (Behar et al., 1996) with Hoxb7-GFP mice (Srinivas et al., 1999) , and examined their ureteric bud branching by confocal microscopy. H7-GFP:Sema3a mice develop slightly below mendelian proportions until E20 (22% Sema3a À/À, 48% Sema3a +/À, 30% Sema3a +/+, n = 214). H7-GFP:Sema3a +/À mice are viable, healthy, fertile and have no obvious renal abnormalities. In contrast, most (95%, n = 58) H7-GFP:Sema3a À/À mice die within 24 h after birth, as previously described (Behar et al., 1996) . As shown in Fig. 5 and Table 2 , ureteric bud branching is consistently increased in H7-GFP:Sema3a null mutants (n = 39) as compared to H7-GFP:Sema3a heterozygous (n = 86) or H7-GFP:Sema3a +/+ littermates (n = 60) between E11.5 and E14.5. Ureteric bud branching in H7-GFP:Sema3a +/À embryos is indistinguishable from H7-GFP:Sema3a +/+ littermates at all ages examined. H7-GFP:sema3a null embryos average 47-64% more ureteric bud tips that their heterozygous littermates from E12 until E13, then the difference gradually decreases until E15 (Table 2) . H7-GFP:Sema3a null mutants do not develop multiple ureteric buds, and the timing of the ureteric bud outgrowth from the Wolffian duct is normal, suggesting that Sema3a is not involved in the guidance of ureteric bud outgrowth. Together, these findings demonstrate that Sema3a functions as an endogenous inhibitor of ureteric bud branching during kidney development.
Discussion
Recent reports show that class 3 semaphorins play important roles in axon pathfinding, vascular patterning and lung branching morphogenesis during embryonic development. However, their role in ureteric bud branching during kidney development is unknown. To define the role of Sema3a in embryonic kidney development we performed in vitro lossand gain-of-function experiments. The present studies demonstrate that Sema3a is an endogenous inhibitor of ureteric bud branching morphogenesis by documenting increased branching upon Sema3a knockdown with antisense morpholinos and decreased branching in the presence of recombinant SEMA3A. Furthermore, we show that SEMA3A competes with VEGF 165 , decreases GDNF expression and signaling and blunts the activity of the Akt survival pathway, suggesting that SE-MA3A function is to restrict ureteric bud branching by modulating GDNF signaling. To validate these findings in vivo we examined Sema3a mutant mice. We report that Sema3a null mice have enhanced ureteric bud branching, confirming the inhibitory role of Sema3a on branching morphogenesis.
To assess the role of Sema3a in ureteric bud branching we performed Sema3a knockdown studies using antisense morpholino oligonucleotides. Morpholinos are oligonucleotides modified to prevent degradation by nucleases that function by translational arrest and have been extensively used to examine gene function (Summerton and Weller, 1997; Feldner et al., 2005; Lee et al., 2002) . We delivered Sema3a morpholinos into embryonic kidneys using a peptide carrier (DMPG) that has been shown to translocate oligonucleotides, cDNA and siRNA into mammalian cells (Morris et al., 1999, 2000) . The morpholino:translocator peptide complexes were microinjected into the ureteric bud lumen (see Fig. 1A and B) to ensure that morpholinos were directly available to ureteric bud cells. DMPG was optimized to translocate oligonucleotides into the cytoplasm (Simeoni et al., 2003) . This peptide was derived from the fusion peptide domain of gp41 protein from HIV1 and the nuclear localization signal from SV40 large T antigen (Morris et al., 1997; Deshayes et al., 2004) . Explant growth and branching morphogenesis were not altered by the presence of DMPG alone, or DMPG bound to mismatched morpholino, indicating that the carrier peptide and the FITC-labeled morpholino backbone are not toxic at the concentrations used. Preliminary experiments indicated that Sema3a antisense or mismatched morpholinos alone did not induce any phenotype change in the explants (data not shown). In contrast, explants exposed to the DMPG: Sema3a antisense morpholino complex 24 h showed a dramatic increase in ureteric bud branching, suggesting that the complex induced Sema3a knockdown. Thus, the morpholino complex microinjection assay allows examining the function of endogenous transcripts in organ culture (see Fig. 1A and B) . Similar results were obtained when the complex was microinjected in the ureteric bud lumen or was added to the explants' media. We were unable to confirm Sema3a knockdown by Western blot because the available SEMA3A antibody crossreacts with SEMA3C and 3F (data not shown). Using in vitro transcription and translation systems, we demonstrated the specificity of the Sema3a antisense morpholino used to knockdown SE-MA3A protein synthesis (see Fig. 1C ), supporting the knockdown data obtained in the explants. In vitro translation experiments have been reported in support of the specificity of knockdown experiments (Lee et al., 2002) . The Sema3a loss-of-function phenotype (increased ureteric bud branching) was opposite to that induced by recombinant SEMA3A (decreased ureteric bud branching), strongly supporting the notion that indeed, Sema3a was downregulated by the antisense morpholino complex in the explants. Together, these data clearly indicate that Sema3a inhibits ureteric bud branching morphogenesis in vitro. Our findings are consistent with a recent report demonstrating that branches initiate at sites with minimum local concentration of autocrine inhibitory morphogens (Nelson et al., 2006) .
Morphometric analysis indicated that rSEMA3A decreased explant growth and ureteric bud branching in vitro. The decreased number of ureteric bud tips resulted from both a reduction in the number of branching generations and in the number of lateral branches, providing evidence for SE-MA3A role in patterning ureteric bud branching.
Multiple factors have been shown to decrease ureteric bud branching in vitro including direct inhibitors of branching, molecules that downregulate GDNF or its receptors' signaling, and inhibitors of growth factors that stimulate branching (Grieshammer et al., 2004; Michael and Davies, 2004; Michos et al., 2004; Patterson et al., 2001; Basson et al., 2005; Grisaru et al., 2001; Chi et al., 2004) . Although regulators of branching morphogenesis have been identified, little is known about how the ureteric branching pattern is established. In this report, we describe Sema3a loss-and gain-of-function in vitro phenotypes that are consistent with a role of Sema3a in ureteric bud patterning. The morpholino complex microinjection assay provides insight into the endogenous signals that localize branches to specific domains of the ureteric bud tree.
To establish the relevance of Sema3a role as an inhibitor of ureteric bud branching in vivo we examined Sema3a mutant mice. Two independent strains of Sema3a null mice have been previously reported (Behar et al., 1996; Taniguchi et al., 1997; Serini et al., 2003) . To our knowledge, no renal phenotype has been reported so far. Depending on the genetic background, these mice either die perinatally with cardiac and vascular abnormalities (Behar et al., 1996; Serini et al., 2003) , or are viable and fertile, albeit small and carrying abnormal axon patterning and arrhythmias (Taniguchi et al., 1997; Ieda et al., 2007) . This suggests that the genetic background modulates putative redundant functions among semaphorins that may overcome single gene defects during organogenesis. The H7-GFP:Sema3a null mutants reported here have a mixed genetic background. H7-GFP:Sema3a null mutants are born at slightly below mendelian ratios, as previously reported (Behar et al., 1996) , but do not survive the perinatal period (95% mortality in the first day, 100% at 7 days). H7-GFP:Sema3a null mutant embryos show enhanced ureteric bud branching at all ages examined, indicating that Sema3a functions as an endogenous negative regulator of ureteric branching during normal embryonic kidney development, thus confirming our in vitro data.
How does SEMA3A blunt ureteric bud branching? We show that neuropilin-1, Sema3a receptor (Kolodkin et al., 1997) , is expressed in the ureteric bud, suggesting that SEMA3A may be a direct branching inhibitor. A similar mechanism has been proposed for lung development where Sema3a slows down growth of the budding tips (Ito et al., 2000; Hinck, 2004) . In the lung, SEMA3A is produced in the mesenchyme surrounding the tip of the branching epithelium and the mechanism is thought to be paracrine (Kagoshima and Ito, Hinck, 2004) . In the developing kidney, in contrast, Sema3a and its receptors are expressed by epithelial cells, including ureteric bud cells, raising the possibility that Sema3a regulation of ureteric bud branching would be autocrine (Villegas and Tufro, 2002; and this study) .
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In addition, SEMA3A negatively modulates branching indirectly by decreasing GDNF signaling in the explants, as documented by downregulation of GDNF protein level and reduced RET phosphorylation. SEMA3A decreased Akt phosphorylation and thus presumably the activity of this survival pathway, either as a consequence of downregulation of GDNF signaling (Tang et al., 1998) or directly via NP-1/plexin signaling (Guan et al., 2006) . Whether SE-MA3A signaling induces apoptosis of GDNF expressing cells or regulates GDNF transcription remains to be determined. SEMA3A has been reported to inhibit neural crest cell migration into the hindgut, which is driven by GDNF chemoattractive cues (Eickholt et al., 1999; Shepherd and Raper, 1999) . SEMA3A chemorepellent functions in dorsal root ganglion neurons are modulated by neurotrophic factors including GDNF (Reza et al., 1999; Young et al., 2004) .
We report two lines of evidence suggesting that SEMA3A competes with VEGF 165 to modulate ureteric bud branching. First, VEGF 165 partially rescued the ureteric bud branching defects caused by SEMA3A and second, Sema3a knockdown (or null mutation), that leaves endogenous VEGF-A effects unopposed, stimulated ureteric bud branching. We previously showed that VEGF-A induces growth, vasculogenesis, tubulogenesis and ureteric bud branching in vitro (Tufro-McReddie et al., 1997; Tufro et al., 1999; Tufro, 2000; A. Tufro, unpublished data) . It was recently shown that VEGF-A overexpression stimulates branching of the ureteric bud (Gao et al., 2005) . SEMA3A/VEGF 165 competition for signaling has been shown to occur in endothelial cells and in neuron progenitor cells (Miao et al., 1999; Bagnard et al., 2001; Tamagnone and Comoglio, 2004) but has not been previously demonstrated in metanephric organ culture or during organogenesis. Although it is likely that the pattern of ureteric bud branching results from the sum of multiple positive and negative cues, Akt upon explant exposure to SEMA3A, whereas total Akt remains unchanged.
confirmation of the physiologic relevance of this counterbalancing mechanism between SEMA3A and the major VEGF-A isoform during renal morphogenesis awaits in vivo studies. These experiments do not rule out the possibility that SE-MA3A may also counterbalance other branching stimuli, e.g. Sema3c, another secreted semaphorin expressed by ureteric buds that binds to neuropilin-1 and -2 (Banu et al., 2006) . In summary, we report that Sema3a is a negative regulator of ureteric bud branching morphogenesis. In vitro data suggest that Sema3a functions by downregulating GDNF, decreasing RET signaling and by competing with VEGF 165 . These findings imply a finely balanced crosstalk among SEMA3A, GDNF and VEGF-A signaling pathways in the control of ureteric bud branching morphogenesis and nephron number.
4.
Experimental procedures 4.1.
Generation of recombinant SEMA3A
Recombinant SEMA3A was generated as described (Guan et al., 2006) . Briefly, rat SEMA3A cDNA (NM_017310) was cloned into Eco-RI/NotI of pHIS.Parallel vector (Sheffield et al., 1999) and Escherichia coli BL21 DE3 Codon Plus (Stratagene) were transformed with pHis.Parallel/sema3A and induced with 1 mM IPTG to produce the recombinant protein. The protein was extracted from inclusion bodies in denaturing conditions, refolded with a reducing buffer, followed by an oxidation buffer. rSEMA3A was dialyzed against decreasing urea concentration (100 mM NaCl, 50 mM TrisHCl, 192 mM glycine, 7 mM urea) and concentrated using Amicon Ò Ultra filters (Millipore).
Metanephric organ culture
Kidneys were excised from E11.5 Swiss-Webster mouse embryos and placed in organ culture filters (Millicell-CM, Millipore) in defined media and cultured at 37°C in humidified air + 5% CO 2 for 24-72 h as previously described (Tufro-McReddie et al., 1997; Tufro, 2000) . Media was changed daily. Paired explants were exposed to FITC-labeled Sema3a antisense morpholino (5 0 -aggcaatcccagt gaaccagcccat-3 0 ) or five base pairs mismatched morpholino oligonucleotides (Genetools Inc.), previously bound to a translocator peptide (DMPG) (GALFLGFLGAAGSTMGAWSQPKKK-RKV) (Simeoni et al., 2003) and cultured for 48 h. Morpholinos were mixed with DMPG peptide at 1:5 M ratios and incubated at 37°C for 30 min prior to be added to the culture media as described (Simeoni et al., 2003) . Final morpholino concentrations were 10 lM. In additional experiments, we microinjected Sema3a antisense or mismatched morpholinos [1 nmol/ll] into the ureters of paired explants using glass capillary needles (Femtotips II, Eppendorf), and a semiautomated microperfusion system set at 100-200 hPa (Injectman/Femtojet, Eppendorf), to ensure that the ureteric bud epithelium was exposed to the oligonucleotides. Successful perfusion of the entire ureteric bud lumen was documented by confocal microscopy ( Fig. 1A and B ). Explants were imaged by phase microscopy at 24 and 48 h. In addition, paired explants were exposed to media + vehicle (control) or media + recombinant SEMA3A [300 ng/ ml]. A dose-response curve to rSEMA3A between 50 and 500 ng/ml was obtained.
In vitro transcription/translation
Sema3a in vitro transcription was performed using RiboMAX TM Large Scale RNA Production System (PI300, Promega). Five micrograms of linear pHIS.Parallel/sema3A vector were transcribed and DNAse treated, the resulting mRNA was purified following the manufacturer's protocol. Translation of Sema3a mRNA was performed using TNT * Quick Coupled Transcription/Translation systems (L1170, Promega) following the manufacturer's protocol with few modifications. Briefly, 0.1 lg/ll of Sema3a mRNA and 1-50 lM sema3A antisense or mismatched morpholinos were incubated for 1 h on ice and 1 h at room temperature, then 0.2 lg Sema3a mRNA was added to the rabbit retyculocyte mix + L-[
35 S]-methionine (NEG-772, Perkin-Elmer) and incubated for 90 min at 30°C. Two microliters of these reactions were resolved in 10% SDS-PAGE, gels were dried and S
35
-labeled newly synthesized proteins were identified by autoradiography.
Lectin staining and immunohistochemistry
Explants were cultured for 48 or 72 h and fixed in 10% buffered formalin for 30 min at room temperature, washed in PBS and processed for lectin staining as described (Tufro et al., 1999) . Briefly, explants were equilibrated in PBS+ 50 mM NH 4 Cl for 30 min followed by lectin buffer (PBS/Ca 2+ /Mg 2+ + 0.075% saponin + 0.2% gelatin + 10 mM Hepes) for 10 min and neuraminidase buffer (50 mM Na acetate + 150 mM NaCl + 9 lM CaCl 2 , pH 5.5), digested with 0.1 U/ml neuraminidase (Sigma) to expose glycosaminoglycans in developing glomeruli, washed in lectin buffer for 10 min three times, and stained with rhodamine-labeled peanut lectin agglutinin [10 lg/ml] for 2 h at 37°C. Then, explants were washed twice in lectin buffer for 10 min and stained with FITC-labeled Dolichos biflora agglutinin (DBA) [50 lg/ml] (Vector) for 1 h at 37°C. Localization of neuropilin-1 was examined by immunohistochemistry in E15 mouse kidneys using anti-rat NP-1 antibody (Kolodkin et al., 1997) as previously described (Villegas and Tufro, 2002) . In addition, dual-immunostaining with NP-1 antibody and goat anti-calbindin antibody (SC#76917, Santa Cruz Biotechnology Inc.) was performed to confirm neuropilin-1 expression in ureteric buds. Briefly, paraffin embedded kidney sections were deparaffinized, hydrated, permeabilized with PBS-Triton X 0.3%, blocked with 5% donkey serum, exposed to primary antibodies overnight at 4°C, washed extensively and exposed to donkey Cy2-labeled anti-rabbit IgG and donkey Cy3-labeled anti-goat IgG (Jackson ImmunoResearch Laboratories). Fluorescent stainings were detected by confocal microscopy (Fluoview 300, Olympus).
Confocal image analysis
Images were obtained at 1024 · 1024 pixels at 4· and 10· magnifications using the same detection sensitivities. Morphometric analysis was performed using Image J software (NIH) and images were processed with Adobe photoshop (Adobe). To characterize ureteric bud branching the following parameters were measured in each selected image (see Supplementary data S1): number of branch generations, the length of segments between branchings, number of tips, number of lateral branches, as previously described by Watanabe and Costantini (2004) . Lateral branches were defined as those appearing to emerge from the stalk of the ureteric bud rather than from a bifid or trifid branching (see white branches in Supplementary data S1). Glomeruli were counted directly in each explant. Data were obtained from at least three independent experiments, each including 4-6 paired explants.
Data are expressed as means ± s.e.m., and compared using paired Student t-test or ANOVA, when appropriate. A value of p < 0.05 was considered significant.
Western analysis
Paired explants cultured in control conditions or exposed to rSEMA3A [300 ng/ml] for 48 h, were lysed with modified RIPA buffer (150 mM ClNa, 1.5 mM Cl 2 Mg, 5 mM NaP 2 O 7, 20 mM Hepes, 0.2% Triton X-100, 10% Glycerol, 5 mM EDTA, 50 mM NaF, 2 mM Na 3 VO 4 ) with complete EDTA-free protease inhibitor cocktail (Roche Applied Science). Protein concentration was determined using the bicinchoninic acid assay (Sigma). Proteins (50-100 lg) were resolved in 7-12% SDS-PAGE. Anti-GDNF polyclonal antibody (sc-328, Santa Cruz), anti-phosphorylated pTyr 1062 RET (sc-20252R, Santa Cruz), anti-Akt (#610860, BD Biosciences), anti-phosphorylated pS 472 Akt (#9271, Cell Signaling) were used for immunoblotting followed by HRP-conjugated anti-rabbit antibody (Jackson ImmunoResearch Laboratories Inc.) and signals were visualized using chemoluminescence (ECL, Amersham).
Hoxb7-GFP:Sema3a mice
Sema3a heterozygous mice (Behar et al., 1996) were bred to Hoxb7-GFP mice (Srinivas et al., 1999) to generate a mixed-background line heterozygous for sema3a expressing GFP in the ureteric bud (H7-GFP:Sema3a). H7-GFP:Sema3a +/À mice were bred, embryos were harvested, and kidneys were excised at E11.5, E12, E13, E14, E15 and postnatal day 1. Embryonic kidneys were imaged by confocal microscopy at low magnification (4·-10·) to examine the whole ureteric bud branching pattern. Embryos and newborn mice were genotyped by PCR using the following primers: 5 0 -AGC GCG ATC ACA TGG TCC TG-3 0 and 5 0 -ACG ATC CTG AGA CTT CCA CAC T-3 0 amplifies a 321 bp product of the Hoxb7-GFP transgene (Srinivas et al., 1999) ; 5 0 -GGA AAG AAC AAT GTG CCA AGA CTG-3 0 and 5 0 -GTT CTG CTC CCG GCT CTA AAT CTC-3 0 , and 5 0 -ATG GTT CTG ATA GGT GAG GCATGG-3 0 amplify $400 and $600 bp products in Sema3a +/+ and À/À mice, respectively.
